384 filings
Page 5 of 20
8-K
624h3l4xxc
1 Jun 17
Other Events
12:00am
8-K
0213h3ku 0z
30 May 17
Changes in Registrant's Certifying Accountant
12:00am
8-K
p80aad6
10 May 17
Other Events
12:00am
8-K
xxpuuqw4
3 May 17
Termination of a Material Definitive Agreement
12:00am
8-K
xiusa
1 May 17
Other Events
12:00am
8-K
c96e9n4q4uwaj
28 Apr 17
Entry into a Material Definitive Agreement
12:00am
8-K
4l1 w77vh8f
27 Apr 17
Savara Announces Closing of Merger with Mast Therapeutics
12:00am
8-K
s47hmuqlc gngah
25 Apr 17
Mast Therapeutics and Savara Announce
12:00am
8-K
ryd8w
24 Apr 17
Regulation FD Disclosure
12:00am
8-K
t8i 33gso6odeodnubsc
21 Apr 17
Mast Therapeutics Announces Adjournment of Special Stockholders Meeting
12:00am
8-K
zj3y 2fo3qc3m3xnkur
20 Apr 17
Mast Therapeutics Announces Possible Adjournment of Special Stockholders Meeting to Solicit Additional Votes for Merger with Savara
12:00am
8-K
88npn49z 5pc9
17 Apr 17
Other Events
12:00am
8-K
676lyg8cf4v7d3ukyvq3
11 Apr 17
Other Events
12:00am
8-K
ggae5wgm65r9
10 Apr 17
Mast Therapeutics and Savara Announce Approval to List Common Stock on the Nasdaq Capital Market
12:00am
8-K
3qsyusqgrzt557g0l
28 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
rgwzp 4j40k
16 Mar 17
Mast Therapeutics Sets Date for Special Meeting of Stockholders to Vote on Proposed Merger with Savara
12:00am
8-K
mch voditbwuif
6 Mar 17
Regulation FD Disclosure
12:00am
8-K
j3yqr590gn3l6c ryj
6 Mar 17
Results of Operations and Financial Condition
12:00am
8-K
nk6tbvbfl zqld950i2
26 Jan 17
Shareholder Update / Q4 Shareholder Brief
12:00am
8-K
38v3g1ptdk3sw1
23 Jan 17
Entry into a Material Definitive Agreement
12:00am